Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Intravenous Drug Delivery Devices Market Research Report 2026
Global Intravenous Drug Delivery Devices Market Research Report 2026
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Intravenous Drug Delivery Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Intravenous Drug Delivery Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Intravenous (IV) delivery is an injection or infusion method of drug administration, which means drugs are sent directly into your vein using a needle or tube.
The North American market for Intravenous Drug Delivery Devices is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Intravenous Drug Delivery Devices is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Intravenous Drug Delivery Devices include Baxter International, Becton Dickinson and Company, Pfizer, Schott, Johnson & Johnson, Novartis, Novo Nordisk, B. Braun Melsungen AG, Cardinal Health, Teva Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Intravenous Drug Delivery Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Intravenous Drug Delivery Devices. The Intravenous Drug Delivery Devices market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Intravenous Drug Delivery Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Intravenous Drug Delivery Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
- Baxter International
- Becton Dickinson and Company
- Pfizer
- Schott
- Johnson & Johnson
- Novartis
- Novo Nordisk
- B. Braun Melsungen AG
- Cardinal Health
- Teva Pharmaceuticals
- Eli Lilly and Company
- Gerresheimer
- Insulet Corporation
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Auto-injectors (Syringe and Cartridge Based)
- Pen Injectors
- Others
Segment by Application
- Hospitals
- Nursing Homes
- Home Care
- Others
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Intravenous Drug Delivery Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Intravenous Drug Delivery Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Intravenous Drug Delivery Devices Market Overview
1.1 Product Definition
1.2 Intravenous Drug Delivery Devices by Type
1.2.1 Global Intravenous Drug Delivery Devices Market Value by Type: 2025 vs 2032
1.2.2 Auto-injectors (Syringe and Cartridge Based)
1.2.3 Pen Injectors
1.2.4 Others
1.3 Intravenous Drug Delivery Devices by Application
1.3.1 Global Intravenous Drug Delivery Devices Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Nursing Homes
1.3.4 Home Care
1.3.5 Others
1.4 Global Intravenous Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Intravenous Drug Delivery Devices Revenue 2021–2032
1.4.2 Global Intravenous Drug Delivery Devices Sales 2021–2032
1.4.3 Global Intravenous Drug Delivery Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Intravenous Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Intravenous Drug Delivery Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Intravenous Drug Delivery Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Intravenous Drug Delivery Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Intravenous Drug Delivery Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Intravenous Drug Delivery Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Intravenous Drug Delivery Devices, Product Types and Applications
2.7 Global Key Manufacturers of Intravenous Drug Delivery Devices, Date of Entry into the Industry
2.8 Global Intravenous Drug Delivery Devices Market Competitive Situation and Trends
2.8.1 Global Intravenous Drug Delivery Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Intravenous Drug Delivery Devices Players Market Share by Revenue
2.8.3 Global Intravenous Drug Delivery Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravenous Drug Delivery Devices Market Scenario by Region
3.1 Global Intravenous Drug Delivery Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Intravenous Drug Delivery Devices Sales by Region: 2021–2032
3.2.1 Global Intravenous Drug Delivery Devices Sales by Region: 2021–2026
3.2.2 Global Intravenous Drug Delivery Devices Sales by Region: 2027–2032
3.3 Global Intravenous Drug Delivery Devices Revenue by Region: 2021–2032
3.3.1 Global Intravenous Drug Delivery Devices Revenue by Region: 2021–2026
3.3.2 Global Intravenous Drug Delivery Devices Revenue by Region: 2027–2032
3.4 North America Intravenous Drug Delivery Devices Market Facts & Figures by Country
3.4.1 North America Intravenous Drug Delivery Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Intravenous Drug Delivery Devices Sales by Country (2021–2032)
3.4.3 North America Intravenous Drug Delivery Devices Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravenous Drug Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Intravenous Drug Delivery Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Intravenous Drug Delivery Devices Sales by Country (2021–2032)
3.5.3 Europe Intravenous Drug Delivery Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Drug Delivery Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Intravenous Drug Delivery Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Intravenous Drug Delivery Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Intravenous Drug Delivery Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intravenous Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Intravenous Drug Delivery Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Intravenous Drug Delivery Devices Sales by Country (2021–2032)
3.7.3 Latin America Intravenous Drug Delivery Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Drug Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Drug Delivery Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Intravenous Drug Delivery Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Intravenous Drug Delivery Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Drug Delivery Devices Sales by Type (2021–2032)
4.1.1 Global Intravenous Drug Delivery Devices Sales by Type (2021–2026)
4.1.2 Global Intravenous Drug Delivery Devices Sales by Type (2027–2032)
4.1.3 Global Intravenous Drug Delivery Devices Sales Market Share by Type (2021–2032)
4.2 Global Intravenous Drug Delivery Devices Revenue by Type (2021–2032)
4.2.1 Global Intravenous Drug Delivery Devices Revenue by Type (2021–2026)
4.2.2 Global Intravenous Drug Delivery Devices Revenue by Type (2027–2032)
4.2.3 Global Intravenous Drug Delivery Devices Revenue Market Share by Type (2021–2032)
4.3 Global Intravenous Drug Delivery Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Intravenous Drug Delivery Devices Sales by Application (2021–2032)
5.1.1 Global Intravenous Drug Delivery Devices Sales by Application (2021–2026)
5.1.2 Global Intravenous Drug Delivery Devices Sales by Application (2027–2032)
5.1.3 Global Intravenous Drug Delivery Devices Sales Market Share by Application (2021–2032)
5.2 Global Intravenous Drug Delivery Devices Revenue by Application (2021–2032)
5.2.1 Global Intravenous Drug Delivery Devices Revenue by Application (2021–2026)
5.2.2 Global Intravenous Drug Delivery Devices Revenue by Application (2027–2032)
5.2.3 Global Intravenous Drug Delivery Devices Revenue Market Share by Application (2021–2032)
5.3 Global Intravenous Drug Delivery Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Baxter International
6.1.1 Baxter International Company Information
6.1.2 Baxter International Description and Business Overview
6.1.3 Baxter International Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Baxter International Intravenous Drug Delivery Devices Product Portfolio
6.1.5 Baxter International Recent Developments/Updates
6.2 Becton Dickinson and Company
6.2.1 Becton Dickinson and Company Company Information
6.2.2 Becton Dickinson and Company Description and Business Overview
6.2.3 Becton Dickinson and Company Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Becton Dickinson and Company Intravenous Drug Delivery Devices Product Portfolio
6.2.5 Becton Dickinson and Company Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Pfizer Intravenous Drug Delivery Devices Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Schott
6.4.1 Schott Company Information
6.4.2 Schott Description and Business Overview
6.4.3 Schott Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Schott Intravenous Drug Delivery Devices Product Portfolio
6.4.5 Schott Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Johnson & Johnson Intravenous Drug Delivery Devices Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Novartis Intravenous Drug Delivery Devices Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Novo Nordisk
6.7.1 Novo Nordisk Company Information
6.7.2 Novo Nordisk Description and Business Overview
6.7.3 Novo Nordisk Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Novo Nordisk Intravenous Drug Delivery Devices Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 B. Braun Melsungen AG
6.8.1 B. Braun Melsungen AG Company Information
6.8.2 B. Braun Melsungen AG Description and Business Overview
6.8.3 B. Braun Melsungen AG Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 B. Braun Melsungen AG Intravenous Drug Delivery Devices Product Portfolio
6.8.5 B. Braun Melsungen AG Recent Developments/Updates
6.9 Cardinal Health
6.9.1 Cardinal Health Company Information
6.9.2 Cardinal Health Description and Business Overview
6.9.3 Cardinal Health Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cardinal Health Intravenous Drug Delivery Devices Product Portfolio
6.9.5 Cardinal Health Recent Developments/Updates
6.10 Teva Pharmaceuticals
6.10.1 Teva Pharmaceuticals Company Information
6.10.2 Teva Pharmaceuticals Description and Business Overview
6.10.3 Teva Pharmaceuticals Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Teva Pharmaceuticals Intravenous Drug Delivery Devices Product Portfolio
6.10.5 Teva Pharmaceuticals Recent Developments/Updates
6.11 Eli Lilly and Company
6.11.1 Eli Lilly and Company Company Information
6.11.2 Eli Lilly and Company Description and Business Overview
6.11.3 Eli Lilly and Company Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Eli Lilly and Company Intravenous Drug Delivery Devices Product Portfolio
6.11.5 Eli Lilly and Company Recent Developments/Updates
6.12 Gerresheimer
6.12.1 Gerresheimer Company Information
6.12.2 Gerresheimer Description and Business Overview
6.12.3 Gerresheimer Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Gerresheimer Intravenous Drug Delivery Devices Product Portfolio
6.12.5 Gerresheimer Recent Developments/Updates
6.13 Insulet Corporation
6.13.1 Insulet Corporation Company Information
6.13.2 Insulet Corporation Description and Business Overview
6.13.3 Insulet Corporation Intravenous Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Insulet Corporation Intravenous Drug Delivery Devices Product Portfolio
6.13.5 Insulet Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Drug Delivery Devices Industry Chain Analysis
7.2 Intravenous Drug Delivery Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Drug Delivery Devices Production Mode & Process Analysis
7.4 Intravenous Drug Delivery Devices Sales and Marketing
7.4.1 Intravenous Drug Delivery Devices Sales Channels
7.4.2 Intravenous Drug Delivery Devices Distributors
7.5 Intravenous Drug Delivery Devices Customer Analysis
8 Intravenous Drug Delivery Devices Market Dynamics
8.1 Intravenous Drug Delivery Devices Industry Trends
8.2 Intravenous Drug Delivery Devices Market Drivers
8.3 Intravenous Drug Delivery Devices Market Challenges
8.4 Intravenous Drug Delivery Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Table of Figures
List of Tables
Table 1. Global Intravenous Drug Delivery Devices Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Intravenous Drug Delivery Devices Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Intravenous Drug Delivery Devices Market Competitive Situation by Manufacturers in 2025
Table 4. Global Intravenous Drug Delivery Devices Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Intravenous Drug Delivery Devices Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Intravenous Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Intravenous Drug Delivery Devices Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Intravenous Drug Delivery Devices Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Intravenous Drug Delivery Devices, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Intravenous Drug Delivery Devices, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Intravenous Drug Delivery Devices, Product Types and Applications
Table 12. Global Key Manufacturers of Intravenous Drug Delivery Devices, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravenous Drug Delivery Devices Companies by Tier (Tier 1, Tier 2, Tier 3), based on Intravenous Drug Delivery Devices Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intravenous Drug Delivery Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Intravenous Drug Delivery Devices Sales by Region (K Units), 2021–2026
Table 18. Global Intravenous Drug Delivery Devices Sales Market Share by Region (2021–2026)
Table 19. Global Intravenous Drug Delivery Devices Sales by Region (K Units), 2027–2032
Table 20. Global Intravenous Drug Delivery Devices Sales Market Share by Region (2027–2032)
Table 21. Global Intravenous Drug Delivery Devices Revenue by Region (US$ Million), 2021–2026
Table 22. Global Intravenous Drug Delivery Devices Revenue Market Share by Region (2021–2026)
Table 23. Global Intravenous Drug Delivery Devices Revenue by Region (US$ Million), 2027–2032
Table 24. Global Intravenous Drug Delivery Devices Revenue Market Share by Region (2027–2032)
Table 25. North America Intravenous Drug Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Intravenous Drug Delivery Devices Sales by Country (K Units), 2021–2026
Table 27. North America Intravenous Drug Delivery Devices Sales by Country (K Units), 2027–2032
Table 28. North America Intravenous Drug Delivery Devices Revenue by Country (US$ Million), 2021–2026
Table 29. North America Intravenous Drug Delivery Devices Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Intravenous Drug Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Intravenous Drug Delivery Devices Sales by Country (K Units), 2021–2026
Table 32. Europe Intravenous Drug Delivery Devices Sales by Country (K Units), 2027–2032
Table 33. Europe Intravenous Drug Delivery Devices Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Intravenous Drug Delivery Devices Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Intravenous Drug Delivery Devices Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Intravenous Drug Delivery Devices Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Intravenous Drug Delivery Devices Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Intravenous Drug Delivery Devices Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Intravenous Drug Delivery Devices Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Intravenous Drug Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Intravenous Drug Delivery Devices Sales by Country (K Units), 2021–2026
Table 42. Latin America Intravenous Drug Delivery Devices Sales by Country (K Units), 2027–2032
Table 43. Latin America Intravenous Drug Delivery Devices Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Intravenous Drug Delivery Devices Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Intravenous Drug Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Intravenous Drug Delivery Devices Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Intravenous Drug Delivery Devices Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Intravenous Drug Delivery Devices Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Intravenous Drug Delivery Devices Revenue by Country (US$ Million), 2027–2032
Table 50. Global Intravenous Drug Delivery Devices Sales (K Units) by Type (2021–2026)
Table 51. Global Intravenous Drug Delivery Devices Sales (K Units) by Type (2027–2032)
Table 52. Global Intravenous Drug Delivery Devices Sales Market Share by Type (2021–2026)
Table 53. Global Intravenous Drug Delivery Devices Sales Market Share by Type (2027–2032)
Table 54. Global Intravenous Drug Delivery Devices Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Intravenous Drug Delivery Devices Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Intravenous Drug Delivery Devices Revenue Market Share by Type (2021–2026)
Table 57. Global Intravenous Drug Delivery Devices Revenue Market Share by Type (2027–2032)
Table 58. Global Intravenous Drug Delivery Devices Price (US$/Unit) by Type (2021–2026)
Table 59. Global Intravenous Drug Delivery Devices Price (US$/Unit) by Type (2027–2032)
Table 60. Global Intravenous Drug Delivery Devices Sales (K Units) by Application (2021–2026)
Table 61. Global Intravenous Drug Delivery Devices Sales (K Units) by Application (2027–2032)
Table 62. Global Intravenous Drug Delivery Devices Sales Market Share by Application (2021–2026)
Table 63. Global Intravenous Drug Delivery Devices Sales Market Share by Application (2027–2032)
Table 64. Global Intravenous Drug Delivery Devices Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Intravenous Drug Delivery Devices Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Intravenous Drug Delivery Devices Revenue Market Share by Application (2021–2026)
Table 67. Global Intravenous Drug Delivery Devices Revenue Market Share by Application (2027–2032)
Table 68. Global Intravenous Drug Delivery Devices Price (US$/Unit) by Application (2021–2026)
Table 69. Global Intravenous Drug Delivery Devices Price (US$/Unit) by Application (2027–2032)
Table 70. Baxter International Company Information
Table 71. Baxter International Description and Business Overview
Table 72. Baxter International Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Baxter International Intravenous Drug Delivery Devices Product
Table 74. Baxter International Recent Developments/Updates
Table 75. Becton Dickinson and Company Company Information
Table 76. Becton Dickinson and Company Description and Business Overview
Table 77. Becton Dickinson and Company Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Becton Dickinson and Company Intravenous Drug Delivery Devices Product
Table 79. Becton Dickinson and Company Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Pfizer Intravenous Drug Delivery Devices Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Schott Company Information
Table 86. Schott Description and Business Overview
Table 87. Schott Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Schott Intravenous Drug Delivery Devices Product
Table 89. Schott Recent Developments/Updates
Table 90. Johnson & Johnson Company Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Johnson & Johnson Intravenous Drug Delivery Devices Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Novartis Company Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Novartis Intravenous Drug Delivery Devices Product
Table 99. Novartis Recent Developments/Updates
Table 100. Novo Nordisk Company Information
Table 101. Novo Nordisk Description and Business Overview
Table 102. Novo Nordisk Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Novo Nordisk Intravenous Drug Delivery Devices Product
Table 104. Novo Nordisk Recent Developments/Updates
Table 105. B. Braun Melsungen AG Company Information
Table 106. B. Braun Melsungen AG Description and Business Overview
Table 107. B. Braun Melsungen AG Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. B. Braun Melsungen AG Intravenous Drug Delivery Devices Product
Table 109. B. Braun Melsungen AG Recent Developments/Updates
Table 110. Cardinal Health Company Information
Table 111. Cardinal Health Description and Business Overview
Table 112. Cardinal Health Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Cardinal Health Intravenous Drug Delivery Devices Product
Table 114. Cardinal Health Recent Developments/Updates
Table 115. Teva Pharmaceuticals Company Information
Table 116. Teva Pharmaceuticals Description and Business Overview
Table 117. Teva Pharmaceuticals Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Teva Pharmaceuticals Intravenous Drug Delivery Devices Product
Table 119. Teva Pharmaceuticals Recent Developments/Updates
Table 120. Eli Lilly and Company Company Information
Table 121. Eli Lilly and Company Description and Business Overview
Table 122. Eli Lilly and Company Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Eli Lilly and Company Intravenous Drug Delivery Devices Product
Table 124. Eli Lilly and Company Recent Developments/Updates
Table 125. Gerresheimer Company Information
Table 126. Gerresheimer Description and Business Overview
Table 127. Gerresheimer Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Gerresheimer Intravenous Drug Delivery Devices Product
Table 129. Gerresheimer Recent Developments/Updates
Table 130. Insulet Corporation Company Information
Table 131. Insulet Corporation Description and Business Overview
Table 132. Insulet Corporation Intravenous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Insulet Corporation Intravenous Drug Delivery Devices Product
Table 134. Insulet Corporation Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Intravenous Drug Delivery Devices Distributors List
Table 138. Intravenous Drug Delivery Devices Customers List
Table 139. Intravenous Drug Delivery Devices Market Trends
Table 140. Intravenous Drug Delivery Devices Market Drivers
Table 141. Intravenous Drug Delivery Devices Market Challenges
Table 142. Intravenous Drug Delivery Devices Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Intravenous Drug Delivery Devices
Figure 2. Global Intravenous Drug Delivery Devices Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Intravenous Drug Delivery Devices Market Share by Type: 2025 & 2032
Figure 4. Auto-injectors (Syringe and Cartridge Based) Product Picture
Figure 5. Pen Injectors Product Picture
Figure 6. Others Product Picture
Figure 7. Global Intravenous Drug Delivery Devices Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Intravenous Drug Delivery Devices Market Share by Application: 2025 & 2032
Figure 9. Hospitals
Figure 10. Nursing Homes
Figure 11. Home Care
Figure 12. Others
Figure 13. Global Intravenous Drug Delivery Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Intravenous Drug Delivery Devices Market Size (US$ Million), 2021–2032
Figure 15. Global Intravenous Drug Delivery Devices Sales (K Units), 2021–2032
Figure 16. Global Intravenous Drug Delivery Devices Average Price (US$/Unit), 2021–2032
Figure 17. Intravenous Drug Delivery Devices Report Years Considered
Figure 18. Intravenous Drug Delivery Devices Sales Share by Manufacturers in 2025
Figure 19. Global Intravenous Drug Delivery Devices Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Intravenous Drug Delivery Devices Players: Market Share by Revenue in Intravenous Drug Delivery Devices in 2025
Figure 21. Intravenous Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Intravenous Drug Delivery Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Intravenous Drug Delivery Devices Sales Market Share by Country (2021–2032)
Figure 24. North America Intravenous Drug Delivery Devices Revenue Market Share by Country (2021–2032)
Figure 25. United States Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Intravenous Drug Delivery Devices Sales Market Share by Country (2021–2032)
Figure 28. Europe Intravenous Drug Delivery Devices Revenue Market Share by Country (2021–2032)
Figure 29. Germany Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Intravenous Drug Delivery Devices Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Intravenous Drug Delivery Devices Revenue Market Share by Region (2021–2032)
Figure 36. China Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Indonesia Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Thailand Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Malaysia Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Intravenous Drug Delivery Devices Sales Market Share by Country (2021–2032)
Figure 46. Latin America Intravenous Drug Delivery Devices Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Intravenous Drug Delivery Devices Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Intravenous Drug Delivery Devices Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Intravenous Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Intravenous Drug Delivery Devices by Type (2021–2032)
Figure 56. Global Revenue Market Share of Intravenous Drug Delivery Devices by Type (2021–2032)
Figure 57. Global Intravenous Drug Delivery Devices Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Intravenous Drug Delivery Devices by Application (2021–2032)
Figure 59. Global Revenue Market Share of Intravenous Drug Delivery Devices by Application (2021–2032)
Figure 60. Global Intravenous Drug Delivery Devices Price (US$/Unit) by Application (2021–2032)
Figure 61. Intravenous Drug Delivery Devices Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Related Reports
Global Intravenous Drug Delivery Devices Market Research Report 2024
Intravenous (IV) delivery is an injection or infusion method of drug administration, which means drugs are sent directly into your vein using a needle or tube.
Published Date: 2024-01-17
Pages: 88
USD 2900.00
(Single User License)
Global Intravenous Drug Delivery Devices Market Research Report 2025
The global market for Intravenous Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 89
USD 2900.00
(Single User License)
Intravenous Drug Delivery Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Intravenous Drug Delivery Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 121
USD 3950.00
(Single User License)
Global Intravenous Drug Delivery Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Intravenous Drug Delivery Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 162
USD 4900.00
(Single User License)
Global Intravenous Drug Delivery Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Intravenous Drug Delivery Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 91
USD 4250.00
(Single User License)
Intravenous Drug Delivery Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Intravenous Drug Delivery Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 140
USD 3950.00
(Single User License)
Global Intravenous Drug Delivery Devices Market Research Report 2024
Intravenous (IV) delivery is an injection or infusion method of drug administration, which means drugs are sent directly into your vein using a needle or tube.
Published: 2024-01-17
Pages: 88
USD 2900.00 (Single User License)Global Intravenous Drug Delivery Devices Market Research Report 2025
The global market for Intravenous Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 89
USD 2900.00 (Single User License)Intravenous Drug Delivery Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Intravenous Drug Delivery Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 121
USD 3950.00 (Single User License)Global Intravenous Drug Delivery Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Intravenous Drug Delivery Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 162
USD 4900.00 (Single User License)Global Intravenous Drug Delivery Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Intravenous Drug Delivery Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 91
USD 4250.00 (Single User License)Intravenous Drug Delivery Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Intravenous Drug Delivery Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 140
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research